Upgrade to premium to see the full reasoning behind each conviction change.
Sign in to unlockFair Value Distribution — percentile bands
100.0% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
-8.2%/yr
±1.9% · revenue growth to justify current price
FCF-Based Reverse DCF
-1.0%/yr
±2.5% · FCF growth to justify current price
THE GAP
Market pricing margin compression or rising capex
Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.
Sign in to unlockFiserv payments/fintech moat; Clover POS growing; banking core processor sticky revenue.
Fintech competition in SMB POS; margin compression; execution risk on large bank wins.
Updated Apr 7
FISV Q4 miss but debt now 3x EBITDA (key overhang clearing). Clover 23% 2025, guided 10-15% 2026. Stock at 56 = 7x adj EPS, 130% discount to DCF FV 129. Maintain conviction 7. Watch Q1 April 23 for Cl...
FISV: Stable recurring revenue fortress with debt/execution headwinds. 80% non-discretionary processing/services, strong cash generation, but transformation risk and elevated leverage require caution....